CVEvulnerability
CVE-2023-23918
7.5 HIGH
Official page ↗
- Status
- Modified
- Published
- 2023-02-23
- Last modified
- 2026-10-24
- Assigner
- [email protected]
- CVSS 3.1 ([email protected])
- 7.5 HIGH — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- CVSS 3.1 (134c704f-9b21-4f2e-91b3-4a467353bcc0)
- 7.5 HIGH — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- Weaknesses
- CWE-863
Description
A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) feature in Node.js and access non authorized modules by using process.mainModule.require(). This only affects users who had enabled the experimental permissions option with --experimental-policy.
Affected configurations
• nodejs node.js (>= 14.0.0 <= 14.14.0)
• nodejs node.js (>= 14.0.0 < 14.21.3)
• nodejs node.js (>= 16.0.0 <= 16.12.0)
• nodejs node.js (>= 16.0.0 < 16.19.1)
• nodejs node.js (>= 18.0.0 <= 18.11.0)
• nodejs node.js (>= 18.0.0 < 18.14.1)
• nodejs node.js (>= 19.0.0 < 19.6.1)
Related
Weakness · CWE (1)
- CWE-863 Incorrect Authorization weakness
References
- https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/ Patch, Vendor Advisory
- https://security.netapp.com/advisory/ntap-20230316-0008/ security.netapp.com
- https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/ Patch, Vendor Advisory
- https://security.netapp.com/advisory/ntap-20230316-0008/ security.netapp.com